Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 274Other solid neoplasm 26Tumor-Agnostic 12Gastrointestinal 12Gynecologic 11Head & Neck 10Breast 10Genitourinary 7CNS 4Sarcoma 3Dermatologic 3NET 1Lymphoid 1Endocrine 1

Conditions

Sezary Syndrome 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1

Interventions

Rituximab 530Cyclophosphamide 424Vincristine 219Doxorubicin 192fludarabine phosphate 176Etoposide 167Prednisone 166fludarabine 162Methotrexate 161Cytarabine 157Filgrastim 125Dexamethasone 123Lenalidomide 121Granulocyte Colony-Stimulating Factor 116Whole-Body Irradiation 106Mycophenolic Acid 98ibrutinib 97Bendamustine Hydrochloride 91Tacrolimus 87Melphalan 85Calcium Dobesilate 82Bortezomib 80Peripheral Blood Stem Cell Transplantation 79Busulfan 78obinutuzumab 64ofatumumab 59Radiotherapy 57Cyclosporine 57Antilymphocyte Serum 55Brentuximab Vedotin 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pemetrexed × Lymphoid × Clear all
NCT00369629 2019-08-28

Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome

Northwestern University

Phase 1 Terminated
14 enrolled 7 charts
DermatologicLymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡